Predictiv AI Announces Sale Of 34 ThermalPass Devices

Predictiv AI (TSXV: PAI) continues to see orders flow in for its ThermalPass fever detection system. The company this morning provided a further update on the sales exhibited by the sensor based screening system, with the announcement of an additional 34 units being sold.

The 34 units have been sold since the company’s previous announcement related to sales in early December. The additional units were reportedly sold to aboriginal communities, prisons, hospitals and public schools across both Canada and the US. The company is currently focusing on sales expansion across a number of sectors, including retail, professional sports, cruise lines, manufacturers, and a number of corporations.

Total sales figures have hit 62 devices as of the latest update, with the devices being officially on the market for a period of seven weeks. While early stage figures, the company has referred to these sales as being “foundational,” stating, “we see strong potential to receive large batch orders from these same customers in Q1 2021 and beyond.”

Predictiv AI last traded at $0.18 on the TSX Venture.


FULL DISCLOSURE: Predictiv AI Inc is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Predictiv AI Inc on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator

In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company...

Wednesday, November 25, 2020, 02:31:06 PM

Theresa Tam Sits Down With Mrs. Clause To Tell Kids They’re On The ‘Good List’ If Vaccinated

In what is likely the most uncomfortable and cringiest video of 2022, Canada’s Chief Public...

Saturday, December 24, 2022, 09:00:00 AM

Auditor General Cites $27.4 Billion COVID Benefit Payments Still Unverified, $4.6 Billion Overpayments To Ineligible Recipients

The report also noted the successful speed in obtaining and distributing COVID-19 vaccines but millions...

Wednesday, December 7, 2022, 07:56:44 AM

Revive Selects Clinical Sites for FDA Phase 3 Clinical Trials

This morning Revive Therapeutics Ltd (CSE: RVV, OTV: RVVTF), announced they have selected five clinical...

Tuesday, September 29, 2020, 09:45:22 AM

Sona Nanotech Approved For Clinical Trials of Saliva-Based COVID-19 Rapid Test

Sona Nanotech (CSE: SONA) has been approved to begin clinical trials. The company this morning...

Tuesday, April 13, 2021, 08:21:40 AM